Skip to content

Lyfstone Calprotectin for synovial fluid

by Calpro AS Norway EUDAMED

Ref LYFCLP005 EMDN W01010699

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-07090028590051 Basic UDI-DIDate25 Jun 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 25 Oct 2026

Device Name
Lyfstone Calprotectin for synovial fluid
Model / Reference
LYFCLP005
Primary DI / UDI-DI
07090028590051
Basic UDI-DI
B-07090028590051
EMDN Code
W01010699 Clin. chem. rt & poc - other
Device Class
Class IVD General
Market of Registration
Norway

Manufacturer details

EUDAMED SRN
NO-MF-000036194

Other devices from Calpro AS

See all devices from Calpro AS →

Properties & raw data

Show properties, registry sources and raw records
  • Reagent
  • Near-Patient Testing
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED 07090028590051|B-07090028590051 61 fields · synced 25 Oct 2026